11/04/2024 11/04/2024Revision of the EU General Pharmaceutical Legislation: more of a compromise than a robust view on the future of biotech innovation in Europe
09/04/2024 09/04/2024Life science industry concerns over the workability of EU HTA: Europe cannot miss out on the opportunity to speed up access to innovative medicines for European patients